Nothing is perfect. That can certainly be said for the comprehensive front-health-page article the New York Times ran this Saturday, April 5, on the high cost of new type 1 diabetes tools.
Read more
DiabetesMine – New York Times on Costs of T1 Diabetes: Dissing Innovation?
Posted in Type I Glucose & Insulin